“Pharmacological Evaluation of CB2 Receptor Modulator in the Treatment of Neuropathic Pain”. Journal of Carcinogenesis, vol. 24, no. 2s, Sept. 2025, pp. 867-85, https://doi.org/10.64149/J.Carcinog.24.2s.867-885.